(Q43767224)

26 November 2017

title

Monotherapy with metformin: does it improve hypoxia in type 2 diabetic patients? (English)

1 reference

26 November 2017

1 reference

1 reference

V Cosić

1

1 reference

26 November 2017

S Antić

2

1 reference

26 November 2017

M Pesić

3

1 reference

26 November 2017

O Jovanović

4

1 reference

26 November 2017

S Kundalić

5

1 reference

26 November 2017

V B Djordjević

6

1 reference

26 November 2017

publication date

1 September 2001

1 reference

Clinical Chemistry and Laboratory Medicine

26 November 2017

published in

1 reference

26 November 2017

volume

39

1 reference

26 November 2017

issue

9

1 reference

26 November 2017

page(s)

818-821

1 reference

Effect of repaglinide addition to metformin monotherapy on glycemic control in patients with type 2 diabetes.

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.135

Metabolic effects of metformin on glucose and lactate metabolism in noninsulin-dependent diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.135

Effects of metformin on insulin resistance, risk factors for cardiovascular disease, and plasminogen activator inhibitor in NIDDM subjects. A study of two ethnic groups.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.135

The antidiabetic drug metformin elevates receptor tyrosine kinase activity and inositol 1,4,5-trisphosphate mass in Xenopus oocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.135

Membrane glycoprotein PC-1 inhibition of insulin receptor function occurs via direct interaction with the receptor alpha-subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.135

Reversal of increased lymphocyte PC-1 activity in patients with type 2 diabetes treated with metformin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.135

Results of a placebo-controlled study of the metabolic effects of the addition of metformin to sulfonylurea-treated patients. Evidence for a central role of adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.135

Fructosamine: a new approach to the estimation of serum glycosylprotein. An index of diabetic control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.135

21 January 2018

Identifiers

DOI

10.1515/CCLM.2001.135

1 reference

26 November 2017

1 reference